ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 140 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $67,764 | -8.7% | 23,367 | +3.2% | 0.00% | 0.0% |
| Q4 2022 | $74,233 | -9.5% | 22,632 | +4.9% | 0.00% | 0.0% |
| Q3 2022 | $82,000 | -50.9% | 21,575 | +0.6% | 0.00% | -50.0% |
| Q2 2022 | $167,000 | -11.6% | 21,445 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $189,000 | -38.2% | 20,315 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $306,000 | -12.1% | 19,390 | -0.4% | 0.00% | -33.3% |
| Q3 2021 | $348,000 | +16.0% | 19,467 | +0.8% | 0.00% | +50.0% |
| Q2 2021 | $300,000 | -2.9% | 19,319 | -10.1% | 0.00% | -33.3% |
| Q1 2021 | $309,000 | -23.1% | 21,492 | +5.0% | 0.00% | -25.0% |
| Q4 2020 | $402,000 | +51.1% | 20,472 | -0.2% | 0.00% | +33.3% |
| Q3 2020 | $266,000 | +18.8% | 20,519 | +33.7% | 0.00% | 0.0% |
| Q2 2020 | $224,000 | +130.9% | 15,349 | +34.2% | 0.00% | +50.0% |
| Q1 2020 | $97,000 | – | 11,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 2,932,865 | $48,304,000 | 3.48% |
| Camber Capital Management LP | 2,950,000 | $48,587,000 | 2.47% |
| Trellus Management Company, LLC | 87,873 | $1,447,000 | 2.42% |
| Redmile Group, LLC | 4,648,570 | $76,562,000 | 1.83% |
| Baupost Group | 8,308,900 | $136,848,000 | 1.51% |
| MAVERICK CAPITAL LTD | 4,958,431 | $81,665,000 | 1.19% |
| Artal Group S.A. | 1,750,000 | $28,823,000 | 1.11% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 175,000 | $2,882,000 | 0.36% |
| 12 West Capital Management LP | 158,700 | $2,614,000 | 0.16% |
| WASATCH ADVISORS LP | 1,101,103 | $18,135,000 | 0.15% |